<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37947962</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-6293</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Current neurology and neuroscience reports</Title><ISOAbbreviation>Curr Neurol Neurosci Rep</ISOAbbreviation></Journal><ArticleTitle>Autonomic Manifestations of Long-COVID Syndrome.</ArticleTitle><Pagination><StartPage>881</StartPage><EndPage>892</EndPage><MedlinePgn>881-892</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11910-023-01320-z</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">Long-COVID is a novel condition emerging from the COVID-19 pandemic. Long-COVID is characterized by symptoms commonly seen in autonomic disorders including fatigue, brain fog, light-headedness, and palpitations. This article will critically evaluate recent findings and studies on Long-COVID and its physiological autonomic manifestations.</AbstractText><AbstractText Label="RECENT FINDINGS">Studies have reported on the prevalence of different symptoms and autonomic disorders in Long-COVID cohorts. Autonomic nervous system function, including both the parasympathetic and sympathetic limbs, has been studied using different testing techniques in Long-COVID patients. While numerous mechanisms may contribute to Long-COVID autonomic pathophysiology, it is currently unclear which ones lead to a Long-COVID presentation. To date, studies have not tested treatment options for autonomic disorders in Long-COVID patients. Long-COVID is associated with autonomic abnormalities. There is a high prevalence of clinical autonomic disorders among Long-COVID patients, with limited knowledge of the underlying mechanisms and the effectiveness of treatment options.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hira</LastName><ForeName>Rashmin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Karalasingham</LastName><ForeName>Kavithra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Jacquie R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>Satish R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada. satish.raj@ucalgary.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada. satish.raj@ucalgary.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Neurol Neurosci Rep</MedlineTA><NlmUniqueID>100931790</NlmUniqueID><ISSNLinking>1528-4042</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001342" MajorTopicYN="Y">Autonomic Nervous System Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054972" MajorTopicYN="Y">Postural Orthostatic Tachycardia Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autonomic dysfunction</Keyword><Keyword MajorTopicYN="N">Heart rate variability</Keyword><Keyword MajorTopicYN="N">Initial orthostatic hypotension</Keyword><Keyword MajorTopicYN="N">Long-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Orthostatic hypotension</Keyword><Keyword MajorTopicYN="N">Postural orthostatic tachycardia syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>11</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37947962</ArticleId><ArticleId IdType="doi">10.1007/s11910-023-01320-z</ArticleId><ArticleId IdType="pii">10.1007/s11910-023-01320-z</ArticleId></ArticleIdList><ReferenceList><ReferenceList><Title>Papers of particular interest, published recently, have been highlighted as: &#x2022; Of importance &#x2022;&#x2022; Of major importance</Title><Reference><Citation>World Health Organization WHO Coronavirus (COVID-19) Dashboard with vaccination data. https://covid19.who.int/ . Accessed 1 Oct 2023</Citation></Reference><Reference><Citation>Bozkurt B, Das SR, Addison D, et al. 2022 AHA / ACC key data elements and definitions for cardiovascular and noncardiovascular complications of COVID-19: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circulation. 2022;80:388&#x2013;465.</Citation></Reference><Reference><Citation>Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127:2336&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">23753844</ArticleId><ArticleId IdType="pmc">3756553</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.144501</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies. Clin Med (Northfield Il). 2021;21:63&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh K, Didar M, Alam U, Satkovich E. COVID-19-associated dysautonomia. Cureus. 2021;13:e17156.</Citation><ArticleIdList><ArticleId IdType="pubmed">34532186</ArticleId><ArticleId IdType="pmc">8435208</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="pmc">8893149</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Rigo S, Barbic F, Khalaf K, et al. The Long-COVID autonomic syndrome in hospitalized patients: a one-year prospective cohort study. Eur J Intern Med. 2023; https://doi.org/10.1016/j.ejim.2023.08.018 . This study followed Long-COVID patients over 1 month, 3 months, 6 months, and 12 months. The researchers determined that Long-COVID patients were still experiencing symptoms at the 12 month mark despite indications of improvement at the 1 and 3 month marks.</Citation></Reference><Reference><Citation>St&#xe5;hlberg M, Reistam U, Fedorowski A, et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134:1451&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34390682</ArticleId><ArticleId IdType="pmc">8356730</ArticleId><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis &amp; management. Indian Pacing Electrophysiol J. 2006;6:84&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">16943900</ArticleId><ArticleId IdType="pmc">1501099</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal SM, Landers DB, Hollenberg SM, Turi ZG, Glotzer TV, Tancredi J, Parrillo JE. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J Am Coll Cardiol. 2022;79:2325&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">35381331</ArticleId><ArticleId IdType="pmc">8976261</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn D-I, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30:449&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">32880754</ArticleId><ArticleId IdType="pmc">7471493</ArticleId><ArticleId IdType="doi">10.1007/s10286-020-00727-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19:1880&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35853576</ArticleId><ArticleId IdType="pmc">9287587</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey J, Lavelle B, Miller J, et al. Multidisciplinary center care for Long COVID syndrome &#x2013; a retrospective cohort study. Am J Med. 2023; https://doi.org/10.1016/j.amjmed.2023.05.002 .</Citation></Reference><Reference><Citation>van Campen C(L)MC, Visser FC. Orthostatic intolerance in Long-Haul COVID after SARS-CoV-2: a case-control comparison with post-EBV and insidious-onset myalgic encephalomyelitis/chronic fatigue syndrome patients. Healthcare. 2022;10:1&#x2013;12.</Citation></Reference><Reference><Citation>Shah B, Kunal S, Bansal A, et al. Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence. Indian Pacing Electrophysiol J. 2022;22:70&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35101582</ArticleId><ArticleId IdType="pmc">8800539</ArticleId><ArticleId IdType="doi">10.1016/j.ipej.2022.01.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69:205&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">33786700</ArticleId><ArticleId IdType="pmc">8009458</ArticleId><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K, Jamal S, Kichloo A, Grubb BP. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Card Rhythm Manag. 2020;11:4302&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33262898</ArticleId><ArticleId IdType="pmc">7685310</ArticleId><ArticleId IdType="doi">10.19102/icrm.2020.111102</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Carneiro D, Rocha I, Habek M, Helbok R, Sellner J, Struhal W, Wenning G, Fanciulli A. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection &#x2013; a systematic review. Eur J Neurol. 2023;30:1528&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">36694382</ArticleId><ArticleId IdType="doi">10.1111/ene.15714</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli A, Leys F, Krbot Skori&#x107; M, et al. Impact of the COVID-19 pandemic on clinical autonomic practice in Europe: a survey of the European Academy of Neurology and the European Federation of Autonomic Societies. Eur J Neurol. 2023;30:1712&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15787</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Boursiquot BC, Moore CJ, Gopinathannair R, Waase MP, Rubin GA, Wan EY. Autonomic dysfunction post&#x2013;acute COVID-19 infection. Heart Case Rep. 2022;8:143&#x2013;6.</Citation></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, Bruchfeld J, Fedorowski A. Long-Haul Post&#x2013;COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021;3:573&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">33723532</ArticleId><ArticleId IdType="pmc">7946344</ArticleId><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Hira R, Baker JR, Siddiqui T, et al. Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can J Cardiol. 2023;39:767&#x2013;75. This study reports on the prevalence of autonomic abnormalities in Long-COVID patients. The researchers implemented an active stand protocol that detected initial orthostatic hypotension in 61% of patients, which has not been reported before.</Citation><ArticleIdList><ArticleId IdType="pubmed">36509178</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2022.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart JM, Kota A, Donnell-smith MBO, Visintainer P, Terilli C, Medow MS. The preponderance of initial orthostatic hypotension in postural tachycardia syndrome. J Appl Physiol. 2023;129:459&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00540.2020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon RS, Grubb BP, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">25980576</ArticleId><ArticleId IdType="pmc">5267948</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2015.03.029</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31:385&#x2013;94. This study was one of the first to implement a full autonomic function screening using a range of autonomic function tests in a Long-COVID cohort.</Citation><ArticleIdList><ArticleId IdType="pubmed">33860871</ArticleId><ArticleId IdType="pmc">8050227</ArticleId><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany&#xf3; J, Bazan V, Llad&#xf3;s G, et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep. 2022;12:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03831-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Tomalia VA. Orthostatic hypotension: mechanisms, causes, management. J Clin Neurol. 2015;11:220&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26174784</ArticleId><ArticleId IdType="pmc">4507375</ArticleId><ArticleId IdType="doi">10.3988/jcn.2015.11.3.220</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study. J Neurol. 2022;269:587&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">34386903</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh NA, Phillips AA, Ranada S, et al. Mitigating initial orthostatic hypotension: mechanistic roles of muscle contraction versus sympathetic activation. Hypertension. 2022;79:638&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">34990207</ArticleId><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.121.18580</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan A, Jennings G, Xue F, Byrne L, Duggan E, Romero-Ortuno R. Orthostatic intolerance in adults reporting Long COVID symptoms was not associated with postural orthostatic tachycardia syndrome. Front Physiol. 2022;13:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.833650</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole M, Moya A, De Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">29562304</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehy037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivasi G, Groppelli A, Brignole M, et al. Association between hypotension during 24h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study. Eur Heart J. 2022;43:3765&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">35766175</ArticleId><ArticleId IdType="pmc">9553097</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehac347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharad B, Rivasi G, Hamrefors V, Johansson M, Ungar A, Sutton R, Brignole M, Parati G, Fedorowski A. Twenty-four-hour ambulatory blood pressure profile in patients with reflex syncope and matched controls. J Am Heart Assoc. 2023;12:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.028704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SHY, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, Mainali S, Bassetti C, Suarez JI, McNett M. Global incidence of neurological manifestations among patients hospitalized with COVID-19 - a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JR, Kimpinski K. Methods of laboratory evaluation of the autonomic nervous system in wakefulness and sleep. In: Chokroverty S, Cortelli P, editors. Auton. Nerv. Syst. Sleep, First. Springer; 2021. p. 79&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-62263-3_9</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA. Testing the autonomic nervous system. Semin Neurol. 2003;23:407&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">15088262</ArticleId><ArticleId IdType="doi">10.1055/s-2004-817725</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji SS, Alabsi HS, Systrom D, Marciano SP, Felsenstein D, Mullally WJ, Pilgrim DM. Multisystem involvement in post-acute sequelae of coronavirus disease 19 survey of autonomic symptoms. Am Neurol Assoc. 2022;91:367&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId></ArticleIdList></Reference><Reference><Citation>Milovanovic B, Djajic V, Bajic D, Djokovic A, Krajnovic T, Jovanovic S, Verhaz A, Kovacevic P, Ostojic M. Assessment of autonomic nervous system dysfunction in the early phase of infection with SARS-CoV-2 virus. Front Neurosci. 2021;15:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.640835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P, O&#x2019;Sullivan O, Houston A, et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm. 2022;19:613&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">34896622</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2021.12.005</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Rigo S, Urechie V, Diedrich A, Okamoto LE, Biaggioni I, Shibao CA. Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome - a case-control study. Bioelectron Med. 2023;9:1&#x2013;9. The authors used spectral analyses to quantify sympathetic and parasympathetic activity among Long-COVID-POTS patients compared to healthy controls.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42234-023-00121-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai T, Zhou D, Yushanjiang F, Wang D, Zhang D, Liu X, Song J, Zhang J, Hou X, Ma Y. Alternation of the autonomic nervous system is associated with pulmonary sequelae in patients with COVID-19 after six months of discharge. Front Physiol. 2022;12:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.805925</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques KC, Silva CC, da Silva Trindade S, de Souza Santos MC, Rocha RSB, da Costa Vasconcelos PF, Quaresma JAS, Falc&#xe3;o LFM. Reduction of cardiac autonomic modulation and increased sympathetic activity by heart rate variability in patients with long COVID. Front Cardiovasc Med. 2022;9:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.862001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin A, Amah G, Chakroun S, et al. Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of. Sci Reports. 2023;131(13):1&#x2013;12.</Citation></Reference><Reference><Citation>Mol MBA, Strous MTA, van Osch FHM, Jeroen Vogelaar F, Barten DG, Farchi M, Foudraine NA, Gidron Y. Heart-rate-variability (HRV), predicts outcomes in COVID-19. PLoS One. 2021;16:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0258841</ArticleId></ArticleIdList></Reference><Reference><Citation>Asarcikli LD, Hayiroglu M&#x130;, Osken A, Keskin K, Kolak Z, Aksu T. Heart rate variability and cardiac autonomic functions in post-COVID period. J Interv Card Electrophysiol. 2022;63:715&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">35106678</ArticleId><ArticleId IdType="pmc">8806134</ArticleId><ArticleId IdType="doi">10.1007/s10840-022-01138-8</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Menezes Junior A, Schr&#xf6;der AA, Botelho SM, Resende AL. Cardiac autonomic function in Long COVID-19 using heart rate variability: an observational cross-sectional study. J Clin Med. 2023;12:1&#x2013;9.</Citation></Reference><Reference><Citation>Karakayal&#x131; M, Artac I, Ilis D, Omar T, Rencuzogullari I, Karabag Y, Altunova M, Arslan A, Guzel E. Evaluation of outpatients in the post-COVID-19 period in terms of autonomic dysfunction and silent ischemia. Cureus. 2023;15:1&#x2013;9.</Citation></Reference><Reference><Citation>Zanin A, Amah G, Chakroun S, et al. Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of &#x201c;long-COVID&#x201d; patients. Sci Rep. 2023;13:8251.</Citation><ArticleIdList><ArticleId IdType="pubmed">37217645</ArticleId><ArticleId IdType="pmc">10201474</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-35086-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H, Chan JF-W, Yuen TT-T, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1:e14&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">32835326</ArticleId><ArticleId IdType="pmc">7173822</ArticleId><ArticleId IdType="doi">10.1016/S2666-5247(20)30004-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId></ArticleIdList></Reference><Reference><Citation>Franca RA, Ugga L, Guadagno E, Russo D, Del Basso De Caro M. Neuroinvasive potential of SARS-CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim? APMIS. 2021;129:37&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">33098147</ArticleId><ArticleId IdType="doi">10.1111/apm.13092</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2020;242(24):168&#x2013;75.</Citation></Reference><Reference><Citation>Zhou L, Zhang M, Wang J, Gao J. Sars-Cov-2: underestimated damage to nervous system. Travel Med Infect Dis. 2020;36:101642.</Citation><ArticleIdList><ArticleId IdType="pubmed">32220634</ArticleId><ArticleId IdType="pmc">7269702</ArticleId><ArticleId IdType="doi">10.1016/j.tmaid.2020.101642</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224:1839&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">34677601</ArticleId><ArticleId IdType="pmc">8643408</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, Fong SW, Young BE, et al. Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open forum. Infect Dis. 2021;8:ofab156.</Citation></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodriguez Y, Zapata E, Ramirez-Santana C, Anaya JM. Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis. 2022;225:2155&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">35079804</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller SN, Rouse BT. Immune responses to viruses. In: Clin. Immunol. Elsevier; 2008. p. 421&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-04404-2.10027-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Krishnamachary B, Spikes L, Chalise P, Dhillon NK. Persistent presence of spike protein and Viral RNA in the circulation of individuals with post-acute sequelae of COVID-19. medRxiv. 2022;95:e28568.</Citation></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">36517603</ArticleId><ArticleId IdType="pmc">9749650</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Kervevan J, Staropoli I, Slama D, et al. Divergent adaptive immune responses define two types of long COVID. Front Immunol. 2023;14:1221961.</Citation><ArticleIdList><ArticleId IdType="pubmed">37559726</ArticleId><ArticleId IdType="pmc">10408302</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1221961</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, Shafiq M, Fitzek A, et al. Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathol. 2023;146:387&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">37452829</ArticleId><ArticleId IdType="pmc">10412500</ArticleId><ArticleId IdType="doi">10.1007/s00401-023-02612-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasty F, Garc&#xed;a G, D&#xe1;vila CH, Wittels SH, Hendricks S, Chong S. Heart rate variability as a possible predictive marker for acute inflammatory response in COVID-19 patients. Mil Med. 2021;186:E34&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206183</ArticleId><ArticleId IdType="pmc">7717314</ArticleId><ArticleId IdType="doi">10.1093/milmed/usaa405</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20:102792.</Citation><ArticleIdList><ArticleId IdType="pubmed">33610751</ArticleId><ArticleId IdType="pmc">7892316</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J. 2022;59:2102245.</Citation><ArticleIdList><ArticleId IdType="pubmed">34531277</ArticleId><ArticleId IdType="pmc">8462012</ArticleId><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O, Halpert G, Schimke LF, et al. The relationship between autoantibodies targeting GPCRs and the renin-angiotensin system associates with COVID-19 severity. Nat Commun. 2021; https://doi.org/10.1101/2021.08.24.21262385 .</Citation></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, H&#xf6;nicke AS, M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100.</Citation><ArticleIdList><ArticleId IdType="pubmed">33880442</ArticleId><ArticleId IdType="pmc">8049853</ArticleId><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019;285:352&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">30372565</ArticleId><ArticleId IdType="doi">10.1111/joim.12852</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Li H, Murphy TA, Nuss Z, Liles J, Liles C, Aston CE, Raj SR, Fedorowski A, Kem DC. Angiotensin II type 1 receptor autoantibodies in postural tachycardia syndrome. J Am Heart Assoc. 2018;7:e008351.</Citation><ArticleIdList><ArticleId IdType="pubmed">29618472</ArticleId><ArticleId IdType="pmc">6015435</ArticleId><ArticleId IdType="doi">10.1161/JAHA.117.008351</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Li H, Yu X, et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017;19:1211&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27702852</ArticleId><ArticleId IdType="doi">10.1093/europace/euw154</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3:e000755.</Citation><ArticleIdList><ArticleId IdType="pubmed">24572257</ArticleId><ArticleId IdType="pmc">3959717</ArticleId><ArticleId IdType="doi">10.1161/JAHA.113.000755</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane C, van Wijnen VK, Fan CW, et al. A practical guide to active stand testing and analysis using continuous beat-to-beat non-invasive blood pressure monitoring. Clin Auton Res. 2019;29:427&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">31076939</ArticleId><ArticleId IdType="doi">10.1007/s10286-019-00606-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieling W, Krediet CTP, Van Dijk N, Linzer M, Tschakovsky ME. Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond). 2007;112:157&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">17199559</ArticleId><ArticleId IdType="doi">10.1042/CS20060091</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, Numan M, Peltier A, Snapper H, Vernino S. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Aut Res. 2021;31:365&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Green EA, Raj V, Shibao CA, Biaggioni I, Black BK, Dupont WD, Robertson D, Raj SR. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc. 2013;2:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000395</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I, Luft FC, Jordan J. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation. 2002;105:347&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">11804991</ArticleId><ArticleId IdType="doi">10.1161/hc0302.102597</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent S, Bieck PR, Garland EM, Loghin C, Bymaster FP, Black BK, Gonzales C, Potter WZ, Robertson D. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation. 2004;109:3202&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15184278</ArticleId><ArticleId IdType="doi">10.1161/01.CIR.0000130847.18666.39</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Ols&#xe9;n MF, Nikesj&#xf6; F, Janson C, Bruchfeld J, Lerm M, Hedman K. Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management. J Intern Med. 2023;294:548&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">37183186</ArticleId><ArticleId IdType="doi">10.1111/joim.13652</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Guzman JC, Harvey P, Richer L, Schondorf R, Seifer C, Thibodeau-Jarry N, Sheldon RS. Canadian Cardiovascular Society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020;36:357&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145864</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2019.12.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. Can Med Assoc J. 2022;194:E378&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.211373</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland EM, Gamboa A, Nwazue VC, et al. Effect of high dietary sodium intake in patients with postural tachycardia syndrome. J Am Coll Cardiol. 2021;77:2174&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">33926653</ArticleId><ArticleId IdType="pmc">8103825</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2021.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourne KM, Sheldon RS, Hall J, et al. Compression garment reduces orthostatic tachycardia and symptoms in patients with postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2021;77:285&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">33478652</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2020.11.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes T, Bara&#xfa;na VG, Negr&#xe3;o CE, Ian Phillips M, Oliveira EM. Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs. Am J Physiol Heart Circ Physiol. 2015;309:H543&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">26071549</ArticleId><ArticleId IdType="pmc">4537939</ArticleId><ArticleId IdType="doi">10.1152/ajpheart.00899.2014</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons CH, Silva G, Freeman R. Cardiovascular exercise as a treatment of postural orthostatic tachycardia syndrome: a pragmatic treatment trial. Heart Rhythm. 2021;18:1361&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33482385</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2021.01.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR. Row, row, row your way to treating postural tachycardia syndrome. Heart Rhythm. 2016;13:951&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26738945</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2015.12.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh NA, Ranada S, Lloyd M, et al. Lower body muscle preactivation and tensing mitigate symptoms of initial orthostatic hypotension in young females. Heart Rhythm. 2022;19:604&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">35365286</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2021.12.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, Robertson D. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;120:725&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19687359</ArticleId><ArticleId IdType="pmc">2758650</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.846501</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold AC, Okamoto LE, Diedrich A, Paranjape SY, Raj SR, Biaggioni I, Gamboa A. Low-dose propranolol and exercise capacity in postural tachycardia syndrome a randomized study. Neurology. 2013;80:1927&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">23616163</ArticleId><ArticleId IdType="pmc">3716342</ArticleId><ArticleId IdType="doi">10.1212/WNL.0b013e318293e310</ArticleId></ArticleIdList></Reference><Reference><Citation>Taub PR, Zadourian A, Lo HC, Ormiston CK, Golshan S, Hsu JC. Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2021;77:861&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">33602468</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2020.12.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation. 2005;111:2734&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">15911704</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.497594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B, Grubb BP. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophysiol. 2011;34:750&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">21410722</ArticleId><ArticleId IdType="doi">10.1111/j.1540-8159.2011.03047.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffin ST, Black BK, Biaggioni I, Paranjape SY, Orozco C, Black PW, Dupont WD, Robertson D, Raj SR. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012;9:1484&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">22561596</ArticleId><ArticleId IdType="pmc">3419341</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2012.05.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon R, Raj SR, Rose MS, et al. Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial. J Am Coll Cardiol. 2016;68:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27364043</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2016.04.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Annamaria M, Lupo PP, Foresti S, De Ambroggi G, de Ruvo E, Sciarra L, Cappato R, Calo L. Treatment of inappropriate sinus tachycardia with ivabradine. J Interv Card Electrophysiol. 2016;46:47&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26467151</ArticleId><ArticleId IdType="doi">10.1007/s10840-015-0066-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabtaie SA, Witt CM, Asirvatham SJ. Efficacy of medical and ablation therapy for inappropriate sinus tachycardia: a single-center experience. J Cardiovasc Electrophysiol. 2021;32:1053&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">33566447</ArticleId><ArticleId IdType="doi">10.1111/jce.14942</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third international study on syncope of uncertain etiology (ISSUE-3): a randomized trial. Circulation. 2012;125:2566&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">22565936</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.082313</ArticleId></ArticleIdList></Reference><Reference><Citation>Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014;15:394&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">24630686</ArticleId><ArticleId IdType="doi">10.1016/j.jamda.2014.01.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann H, Freeman R, Low P, Pedder S, Hewitt LA, Mauney J, Feirtag M, Mathias CJ. Droxidopa for neurogenic orthostatic hypotension. Neurology. 2014;83:328&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">24944260</ArticleId><ArticleId IdType="pmc">4115605</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000000615</ArticleId></ArticleIdList></Reference><Reference><Citation>Veazie S, Peterson K, Ansari Y, Chung KA, Gibbons CH, Raj SR, Helfand M. Fludrocortisone for orthostatic hypotension. Cochrane database Syst Rev. 2021;5:CD012868.</Citation><ArticleIdList><ArticleId IdType="pubmed">34000076</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>